GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Sale Of Investment

Eisai Co (TSE:4523) Sale Of Investment : 円2,289 Mil (TTM As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Sale Of Investment?

Eisai Co's sale of investment for the three months ended in Dec. 2023 was 円1,511 Mil. It means Eisai Co gained 円1,511 Mil from selling investments. Eisai Co's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,289 Mil.

Compared with last quarter (円234 Mil in Sep. 2023 ), Eisai Co gained more money from selling investments in Dec. 2023 (円1,511 Mil).

Eisai Co Sale Of Investment Historical Data

The historical data trend for Eisai Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Sale Of Investment Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,615.00 13,039.00 3,749.00 2,490.00 10,046.00

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,983.00 213.00 331.00 234.00 1,511.00

Eisai Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,289 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Eisai Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Sale Of Investment
Comparable Companies
TSE:4507 TSE:4581 TSE:4516 TSE:4530 TSE:4540 TSE:4887 TSE:4506 TSE:4547 TSE:4553 TSE:4521 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA VTRS NBIX XSWX:SDZ SZSE:000538
Traded in Other Exchanges
ESAIY:USA ESALF:USA EII:Germany
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Website
http://www.eisai.co.jp
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines